A Brain-enriched Polypyrimidine Tract-binding Protein Antagonizes the Ability of Nova to Regulate Neuron-specific Alternative Splicing

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2000 Jun 1

PMID 10829067

Citations 117

Authors

A D Polydorides

H J Okano

Y Y Yang

G Stefani

R B Darnell

Affiliations

Soon will be listed here.

Abstract

The Nova paraneoplastic antigens are neuron-specific RNA binding proteins that participate in the control of alternative splicing. We have used the yeast two-hybrid system to isolate Nova interacting proteins and identify an RNA binding protein that is closely related to the polypyrimidine tract-binding protein (PTB). The expression of this protein, brPTB, is enriched in the brain, where it is expressed in glia and neurons. brPTB interacts with Nova proteins in cell lines and colocalizes with Nova within neuronal nuclei. We previously found that Nova binds to a pyrimidine-rich RNA element present upstream of an alternatively spliced exon, E3A, in glycine receptor alpha2 (GlyRalpha2) pre-mRNA, and this binding is implicated in Nova-dependent regulation of splicing. Cotransfection assays with a GlyRalpha2 minigene demonstrate that brPTB antagonizes the action of Nova to increase utilization of GlyRalpha2 E3A. brPTB binds to a 90-nt GlyRalpha2 RNA adjacent to the Nova binding site, but with an affinity that is more than 10-fold lower than Nova. When a putative binding site for brPTB on the GlyRalpha2 RNA is mutated, binding is abolished and the inhibitory effect on Nova-dependent exon selection disappears. These results suggest that brPTB is a tissue-restricted RNA binding protein that interacts with and inhibits the ability of Nova to activate exon selection in neurons.

Citing Articles

Evolutionarily Developed Alternatively Spliced Exons Containing Translation Initiation Sites.

Takeda J, Okamoto T, Masuda A Cells. 2025; 14(1.

PMID: 39791712 PMC: 11719525. DOI: 10.3390/cells14010011.

Coupling of alternative splicing and alternative polyadenylation.

Zhang X, Liu F, Zhou Y Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):22-32.

PMID: 39632657 PMC: 11802343. DOI: 10.3724/abbs.2024211.

RNA and neuronal function: the importance of post-transcriptional regulation.

Bhat V, Jayaraj J, Babu K Oxf Open Neurosci. 2024; 1:kvac011.

PMID: 38596700 PMC: 10913846. DOI: 10.1093/oons/kvac011.

PTBP1 as a potential regulator of disease.

Yu Q, Wu T, Xu W, Wei J, Zhao A, Wang M Mol Cell Biochem. 2023; 479(11):2875-2894.

PMID: 38129625 DOI: 10.1007/s11010-023-04905-x.

Neuronal conversion from glia to replenish the lost neurons.

Liang S, Zhou J, Yu X, Lu S, Liu R Neural Regen Res. 2023; 19(7):1446-1453.

PMID: 38051886 PMC: 10883502. DOI: 10.4103/1673-5374.386400.

References

Zhang L, Liu W, Grabowski P . Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. RNA. 1999; 5(1):117-30. PMC: 1369744. DOI: 10.1017/s1355838299981530. View

Ghetti A, Pinol-Roma S, Michael W, Morandi C, Dreyfuss G . hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 1992; 20(14):3671-8. PMC: 334017. DOI: 10.1093/nar/20.14.3671. View

Singh R, Valcarcel J, Green M . Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science. 1995; 268(5214):1173-6. DOI: 10.1126/science.7761834. View

Modafferi E, Black D . A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol Cell Biol. 1997; 17(11):6537-45. PMC: 232507. DOI: 10.1128/MCB.17.11.6537. View

Perez I, Lin C, McAfee J, Patton J . Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo. RNA. 1997; 3(7):764-78. PMC: 1369523. View

Sommer B, Keinanen K, Verdoorn T, Wisden W, Burnashev N, Herb A . Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science. 1990; 249(4976):1580-5. DOI: 10.1126/science.1699275. View

Southby J, Gooding C, Smith C . Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutally exclusive exons. Mol Cell Biol. 1999; 19(4):2699-711. PMC: 84063. DOI: 10.1128/MCB.19.4.2699. View

Ehlers M, Fung E, OBrien R, Huganir R . Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci. 1998; 18(2):720-30. PMC: 6792537. View

Lin C, Patton J . Regulation of alternative 3' splice site selection by constitutive splicing factors. RNA. 1995; 1(3):234-45. PMC: 1369077. View

10.

Horowitz D, Krainer A . Mechanisms for selecting 5' splice sites in mammalian pre-mRNA splicing. Trends Genet. 1994; 10(3):100-6. DOI: 10.1016/0168-9525(94)90233-x. View

11.

Grabowski P . Genetic evidence for a Nova regulator of alternative splicing in the brain. Neuron. 2000; 25(2):254-6. DOI: 10.1016/s0896-6273(00)80888-0. View

12.

Fan X, Steitz J . Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 1998; 17(12):3448-60. PMC: 1170681. DOI: 10.1093/emboj/17.12.3448. View

13.

Yang Y, Yin G, Darnell R . The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A. 1998; 95(22):13254-9. PMC: 23773. DOI: 10.1073/pnas.95.22.13254. View

14.

Caceres J, Stamm S, Helfman D, Krainer A . Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 1994; 265(5179):1706-9. DOI: 10.1126/science.8085156. View

15.

Okano H, Park W, Corradi J, Darnell R . The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev. 1999; 13(16):2087-97. PMC: 316965. DOI: 10.1101/gad.13.16.2087. View

16.

Hollmann M, Boulter J, Maron C, Beasley L, Sullivan J, Pecht G . Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron. 1993; 10(5):943-54. DOI: 10.1016/0896-6273(93)90209-a. View

17.

Lou H, Helfman D, Gagel R, Berget S . Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon. Mol Cell Biol. 1998; 19(1):78-85. PMC: 83867. DOI: 10.1128/MCB.19.1.78. View

18.

Jensen K, Dredge B, Stefani G, Zhong R, Buckanovich R, Okano H . Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron. 2000; 25(2):359-71. DOI: 10.1016/s0896-6273(00)80900-9. View

19.

Chou M, Rooke N, Turck C, Black D . hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol. 1998; 19(1):69-77. PMC: 83866. DOI: 10.1128/MCB.19.1.69. View

20.

Lewis H, Musunuru K, Jensen K, Edo C, Chen H, Darnell R . Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell. 2000; 100(3):323-32. DOI: 10.1016/s0092-8674(00)80668-6. View